Affiliation:
1. Department of Internal Medicine, Division of Hematology/Oncology, Naef Khaled Basile Cancer Institute—NKBCI, American University of Beirut Medical Center, Beirut 1107 2020, Lebanon
Abstract
Targeted monoclonal antibody therapy against Epidermal Growth Factor Receptor (EGFR) is a leading treatment modality against metastatic colorectal cancer (mCRC). However, with the emergence of KRAS and BRAF mutations, resistance was inevitable. Cells harboring these mutations overexpress Glucose Transporter 1 (GLUT1) and sodium-dependent vitamin C transporter 2 (SVCT2), which enables intracellular vitamin C transport, leading to reactive oxygen species generation and finally cell death. Therefore, high dose vitamin C is proposed to overcome this resistance. A comprehensive search strategy was adopted using Pubmed and MEDLINE databases (up to 11 August 2022). There are not enough randomized clinical trials to support its use in the clinical management of mCRC, except for a subgroup analysis from a phase III study. High dose vitamin C shows a promising role in overcoming EGFR resistance in mCRC with wild KRAS mutation with resistance to anti-epidermal growth factor inhibitors and in patients with KRAS and BRAF mutations.
Subject
General Biochemistry, Genetics and Molecular Biology,Medicine (miscellaneous)
Reference49 articles.
1. Sawicki, T., Ruszkowska, M., Danielewicz, A., Niedźwiedzka, E., Arłukowicz, T., and Przybyłowicz, K.E. (2021). A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers, 13.
2. Diagnosis and Treatment of Metastatic Colorectal Cancer: A Review;Biller;JAMA,2021
3. High-dose intravenous vitamin C, a promising multi-targeting agent in the treatment of cancer;Cahn;J. Exp. Clin. Cancer Res. CR,2021
4. The Role of Anti-EGFR Monoclonal Antibody in mCRC Maintenance Therapy;Yuan;Front. Mol. Biosci.,2022
5. Vitamin C: The known and the unknown and Goldilocks;Padayatty;Oral Dis.,2016
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献